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Abstract 
Sleep and wakefulness are primarily regulated by inhibitory interactions between 
the hypothalamus and brain stem. The expression of the states of rapid eye 
movement (REM) sleep and non-REM (NREM) sleep are also correlated with the 
activity of groups of REM-off and REM-on neurons in the dorsal brain stem. 
However, the contribution of ventral brain stem nuclei to sleep regulation has to 
date been little characterized. Here we examined sleep and wakefulness in mice 
deficient in a homeobox transcription factor, Goosecoid-like (Gscl), which is one 
of the genes deleted in DiGeorge syndrome or 22q11 deletion syndrome. The 
expression of Gscl is restricted to the interpeduncular nucleus (IP) in the ventral 
region of the midbrain-hindbrain transition. The IP has reciprocal connections 
with several cell groups implicated in sleep/wakefulness regulation. Although 
Gscl-/- mice have apparently normal anatomy and connections of the IP, they 
exhibited a reduced total time spent in REM sleep and fewer REM sleep 
episodes. In addition, Gscl-/- mice showed reduced theta power during REM 
sleep and increased arousability during REM sleep. Gscl-/- mice also lacked the 
expression of DiGeorge syndrome critical region 14 (Dgcr14) in the IP. These 
results thus indicate that the absence of Gscl and Dgcr14 in the IP results in 
altered regulation of REM sleep. 
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Introduction 
In vertebrates and invertebrates, sleep is defined behaviorally as a reversible 
quiescence which is regulated in a circadian and homeostatic manner, 
accompanied by an increased threshold to respond to external stimuli (1). In 
mammals and birds, sleep is further classified into rapid eye movement (REM) 
sleep and non-REM (NREM) sleep based on specific brain activity patterns and 
muscle tonus detected by electroencephalography/electromyography 
(EEG/EMG). In rodents, NREM sleep is defined by high amplitude, low frequency 
waves on the EEG, typified by the presence of  the1-4 Hz (i.e.,delta) 
frequencies,; in contrast, REM sleep is characterized by power in the 6-12 Hz 
(i.e., theta) frequency band, which is derived primarily from hippocampal activity, 
combined with a loss of skeletal muscle tone. Switching between the sleeping 
and wakeful states is primarily regulated by inhibitory interactions between the 
hypothalamus and brainstem (2,3).  Switching between NREM and REM states is 
further regulated by inhibitory interactions between populations of neurons in the 
brainstem (3,4).  Although dopaminergic neurons in the ventral midbrain stem 
have been implicated in regulating sleep and wakefulness (5), the role of the 
ventral brain stem in sleep regulation has been less well studied compared to the 
dorsal brain stem. 
 It has been reported that lesions of the bilateral fasciculus retroflexus, a 
major input to the interpeduncular nucleus (IP), result in reduced REM sleep time 
(6, 7). The IP is located on the midline in the ventral region of the midbrain-
hindbrain transition, and evolutionally conserved from fish to mammals. It has 
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reciprocal connections with the median raphe nucleus (MnR), dorsal raphe 
nucleus (DRN), laterodorsal tegmental nucleus (LDTg), and nucleus incertus (NI) 
(8-13), which are implicated in the regulation of sleep and wakefulness and the 
generation of hippocampal theta (2, 3, 14, 15). In addition, the IP receives from 
the basal forebrain via the fasciculus retroflexus directly or relayed at the medial 
habenular nucleus. In turn, the IP innervates the basal forebrain (16). With the 
basal forebrain known to regulate vigilance state, this reciprocal pattern of 
innervation also supports a potential role of the IP in sleep mechanisms. 
However, no studies to date have examined if the IP is involved in sleep.  
This is, in part because of the difficulty of lesioning or locally injecting the IP 
without damaging bilateral dorsal brain stem nuclei and fibers of passage, due to 
the size and position of the IP. A recent comprehensive approach to gene 
expression in the mouse brain revealed that a homeobox transcription factor, 
Goosecoid-like (Gscl), also known as Gsc2, has an expression pattern restricted 
to the IP (17). Gscl is one of the genes deleted in DiGeorge syndrome or 22q11 
deletion syndrome patients, who have a variety of psychiatric symptoms (18). We 
thus examined sleep/wakefulness parameters in the Gscl-/- mouse (19) under 
baseline conditions and also studied REM sleep rebound after REM sleep 
deprivation and the sensory threshold to arousal during sleep in these mice.  
 
 
Results 
Gscl expression is restricted to the IP. We examined the expression pattern of 
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Gscl mRNA at different developmental stages. In the adult brain, Gscl mRNA 
was expressed exclusively in the caudal (IPc) and lateral (IPl) subnuclei of IP 
(Fig. 1A, B). During embryonic development, the expression of Gscl mRNA was 
restricted to the developing ventral midbrain/pons transitional region; a future IP 
region (Fig.1C, D), as reported previously (17, 20). Loss of Gscl did not alter 
subnuclear structures in the Nissl-stained IP and there was no difference in 
position and proportion between Gscl-positive and Gscl-negative subnuclei. 
IP neurons contain several inhibitory neurotransmitters, including GABA, 
somatostatin, and substance P, and IP receives projections of cholinergic, 
serotonergic, and substance P-containing fibers (9, 16, 21). We examined 
whether the loss of Gscl altered the neurochemical characteristics of the IP 
neurons and the input fibers.  When Gscl+/- mice were crossed with the Gad67-
Gfp knock-in line (22), Gscl-/-; Gad67Gfp/+ mice showed diffuse and moderate Gfp 
expression in the entire IP with strong expression in the rostral subnucleus, 
similarly to Gscl+/+; Gad67Gfp/+ mice (Fig. 1E, F). Consistent with the previous 
reports on wild-type mice (9, 16, 21), both Gscl-/- and Gscl+/+ mice showed; (i) 
diffuse choline acetyltransferse (Chat)-immunoreactivity in the IP (Fig. 1G); (ii) 
strong somatostatin-immunoreactivity in the rostral and apical subnuclei (Fig. 
1H); (iii) moderate substance P-immunoreactivity in the IP with prominent 
immunoreactivity in the lateral subnucleus (Fig. 1I); (iv) Met-enkephalin 
immunoreactivity strongly in the dorsolateral subnucleus and moderately in the 
rostral and caudal subnuclei (Fig. 1J); (v) and diffuse 5-HT transporter-
immunoreactivity in the entire IP with scattered strong immunoreactive cells (Fig. 
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1K). Loss of Gscl had no appreciable effects on Gad67-Gfp expression, or 
immunoreactivity for Chat, somatostatin, subtance P and 5-HT transporter 
outside the IP. We also examined the expression of DiGeorge syndrome critical 
region 14 (Dgcr14, also known as Es2) mRNA in the Gscl-/- mouse, an adjacent 
gene to Gscl on both the human and mouse chromosomes. Dgcr14 mRNA was 
strongly expressed in the Gscl+/+ mouse brain in the IPc, IPl, and a part of the 
intermediate subnuclei (Fig. 1I). This was therefore similar to the expression 
pattern of Gscl mRNA in the IP (Fig. 1B). However, the Gscl-/- mouse lacked the 
expression of Dgcr14 mRNA in the IP (Fig. 1J). In contrast to Gscl mRNA, 
Dgcr14 mRNA showed a diffuse and weak expression pattern in the entire brain 
of wild-type mice; this diffuse expression was conserved in Gscl-/- mice. 
To examine whether loss of Gscl affected fiber connections to the IP, we 
injected retrograde tracer, cholera toxin B, in the lateral subnucleus of the IP. 
Labeled cells were recognized in the MnR (Fig. 1K), DRN (Fig. 1L), LDTg (Fig. 
1M), NI (Fig. 1N), median septal nucleus, nucleus of the diagonal band, lateral 
hypothalamus, supramammillary nucleus, and medial habenular nucleus of Gscl-
/- mice. These nuclei were the same as those previously described in wild-type 
mice (Fig. 1O) (8, 9, 10, 12, 13, 23). Injection of anterograde tracer, AAV-GFP in 
the IPl of Gscl-/- and Gscl+/+ mice showed dense efferent fibers throughout 
pontine midline structures, including the MnR, DRN, LDTg, NI, and posterodorsal 
tegmental nucleus (PDTg) (Fig. 1P), as previously described (8, 9, 11). Thus, we 
found no apparent difference between the two genotypes in the afferent and 
efferent fiber connections to/from the IP, although there were small differences in 
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the number of labeled cells and fibers among all tracer-injected brains due to 
inevitable differences in the exact location and amount of tracer injected. 
 
Gscl-deficient mouse shows reduced REM sleep time. Gscl-/- mice exhibited 
a decrease in both total time and episode frequency of REM sleep during the 
light period and over 24 h when compared with Gscl+/+ mice (Table 1, Fig. 2).  
However, no significant difference was noted in REM sleep episode duration 
between Gscl-/- and Gscl+/+ mice (Table 1). REM sleep latency was increased 
during the light period and over 24h in Gscl-/- mice. In addition to a slight but 
significant increase in total NREM sleep time, Gscl-/- mice exhibited a longer 
mean NREM sleep episode duration and reduced NREM sleep episode 
frequency when compared with wild-type mice during the light period and over 24 
h (Table 1). This indicated that the NREM sleep phase in Gscl-/- mice was more 
consolidated in the light period than in Gscl+/+ mice. Wakefulness time and mean 
episode duration were similar in Gscl-/- and wild-type mice, though we noted a 
tendency towards shorter total wakefulness time during the dark period in Gscl-/- 
mice (Table1, Fig. 2). Importantly, the number of transitions from NREM sleep to 
REM sleep was selectively reduced in Gscl-/- mice (Fig. 2D). This is consistent 
with a reduced number of REM sleep episodes, a shorter total REM sleep time, 
and longer duration of NREM sleep episodes. In other words, Gscl-/- mice tend to 
“skip” REM sleep episodes during NREM sleep. 
 
Reduced theta power in Gscl-deficient mouse. EEG spectral analysis of 
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Gscl+/+ and Gscl-/- mice during wakefulness, NREM sleep, and REM sleep 
revealed that EEG power density in the theta frequency range (6-12 Hz) in Gscl-/- 
during REM sleep was significantly reduced compared to Gscl+/+ mice (P=0.002; 
Fig. 3). In addition, we noted that EEG power density in the delta frequency 
range (1-4 Hz) during NREM sleep was greater in Gscl-/- than Gscl+/+ mice 
(P=0.03; Fig. 3). 
 
Increased arousability during REM sleep in Gscl-deficient mouse. While 
vigilance state recordings were being performed in Gscl-/- mice, we observed that 
Gscl-/- mice seemed excessively sensitive to external stimuli during sleep. To 
examine the arousability of Gscl-/- mice, we tested their arousal threshold during 
REM and NREM sleep using acoustic stimuli. In 14 out of 17 trials during REM 
sleep, Gscl-/- mice (n=4) was awakened in response to a standardized acoustic 
stimulus, but Gscl+/+ mice (N=5) remained asleep in 12 out of 13 trials (P<0.001; 
Fig. 4A). In contrast, there was no significant difference in the arousal response 
to acoustic stimuli during NREM sleep (P=0.2). In order to confirm this finding 
with a different modality of stimuli, we measured the time to awaken in response 
to combined acoustic, olfactory, and visual stimuli caused by moving a Latex 
glove close to a mouse. Gscl-/- mice had significantly shorter latencies to awake 
than Gscl+/+ mice during REM sleep (Fig. 4B). 
 
Reduced REM sleep rebound in Gscl-deficient mouse. To examine the 
homeostatic regulation of REM sleep, Gscl-/- mice were deprived of REM sleep 
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from ZT6 to ZT12 and thier REM sleep time was then examined from ZT12 to 
ZT24 when there was no significant difference between Gscl+/+ and Gscl-/- mice in 
baseline REM sleep time (Fig. 2C). After REM sleep deprivation, both Gscl+/+ and 
Gscl-/- mice spent longer in REM sleep than under baseline conditions (Fig. 5A), 
but both the extent and duration of the REM sleep rebound were less in Gscl-/- 
than Gscl+/+ mice. REM sleep deprivation did not affect NREM sleep time in 
either genotype (Fig. 5B). 
 
 
Discussion 
The present study has shown that Gscl-/- mice spend less time in REM sleep, 
express fewer REM sleep episodes and have fewer transitions from NREM sleep 
to REM sleep. Furthermore, these mice have reduced theta power and increased 
arousability during REM sleep. In view of the restricted expression of Gscl to the 
IP combined with a specific loss of expression of Dgcr14 in the IP of Gscl-/- mice, 
these results indicate that the normal function of the IP is required for REM sleep 
regulation. 
 Although Gscl-/- mice showed a reduced theta power, the EEG pattern of 
REM sleep was still clearly different from that of NREM sleep and of 
wakefulness. Moreover, we staged REM sleep based on both the appearance of 
theta wave and loss of muscle tone. Thus, it is unlikely that shorter total time of 
REM sleep or reduced REM sleep rebound of Gscl-/- mice were resulted from a 
mis-scoring of REM sleep.  
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The IP is located at the ventral region of the midbrain-hindbrain transition, 
and has afferent and efferent connections with the basal forebrain and brain 
stem. This suggests that the IP may function as an interface between the basal 
forebrain and brain stem in the modulation of brain function and behavior. 
Although the functional role of the IP remains unknown (16), several findings 
have suggested that the IP may be associated with sleep and wakefulness. 
Unlike most brain regions, glucose utilization in the IP is increased during REM 
sleep as well as under anesthesia, (24, 25, 26). Moreover, bilateral lesions of the 
fasciculus retroflexus, the major afferent path from the IP, decreases the time 
spent in REM sleep (6, 7). However, to date there has been no report directly 
examining the role of the IP in sleep mechanisms primarily because research has 
tended to focus on the dorsal region of the brain stem (2, 3, 4), and because 
surgical procedures targeting the IP inevitably damage bilateral dorsal brain stem 
nuclei as well as fibers connecting the hypothalamus with the brain stem nuclei. 
Among IP subnuclei, Gscl and Dgcr14 are expressed mainly in the caudal 
and lateral structures. These subnuclei send efferent fibers to the MnR and DRN, 
containing serotonergic REM-off neurons, and to the laterodorsal tegmental 
nucleus, containing cholinergic REM-on neurons (3, 9, 11, 27). In addition, the 
caudal and lateral subnuclei send efferent fibers to the NI (8, 9, 11), which relays 
ascending projections from the nucleus pontis oralis to the medial septal nucleus, 
a pathway implicated in hippocampal theta generation (14). Moreover, the IP 
sends a small number of efferent fibers to the hippocampus and medial septal 
nucleus (9, 11). These connections provide an anatomical basis for the IP as a 
 12
regulator of hippocampal theta and REM sleep. 
Another interesting phenotype of the Gscl-/- mouse is increased arousability, 
specifically during REM sleep, in response to external stimuli. This is unlikely due 
to disturbed peripheral sensory processing or increased anxiety, because Gscl-/- 
mice respond normally to acoustic or visual stimuli during NREM sleep or 
wakefulness, and showed normal anxiety behavior (28). External stimuli may 
activate wake-promoting neuons in the brain stem to switch from sleep to 
wakefulness (2, 29). Although increased arousability of Gscl-/- mice suggests an 
altered regulation of wake-promoting neurons in response to sensory stimuli, 
further studies are needed to elucidate the detailed mechanisms. 
Gscl-/- mice exhibited a REM sleep rebound after deprivation, but the 
magnitude and duration of the rebound was smaller than in wild-type mice. Since 
Gscl-/- mice spend less time in REM sleep than wild-type mice under baseline 
conditions, the reduced REM sleep rebound may be due to a smaller need for 
REM sleep in Gscl-/- mice after 6 h of REM sleep deprivation. However, it is also 
possible that the mechanisms of REM sleep rebound per se are affected in the 
knockout mouse.  
The accentuated expression in the IP of Dgcr14 was absent in the Gscl-/- 
mouse, in which the entire Gscl gene was replaced with the puromycin 
resistance and hygromycin resistance genes (19). Another strain of Gscl-/- 
mouse, in which the entire Gscl gene was replaced with the neomycin resistance 
gene, also showed a loss of Dgcr14 expression in the IP (30). Dgcr14 is located 
only 2-kb downstream of Gscl with the same transcription direction, suggesting 
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that Gscl contains a cis regulatory element required for the high expression of 
Dgcr14 in IP subnuclei. Downstream of Dgcr14, there are two genes, Testis-
specific serine kinase 2 (Tssk2) and Tssk1, but in the opposite transcription 
direction and both Tssk1 and Tssk2 are not expressed in the brain except in the 
piriform cortex (18; Allen Brain Atlas, http://mouse.brain-map.org/). Hence, loss of 
Gscl and Dgcr14 expression in the IP may be sufficient to cause the altered 
regulation of sleep/wakefulness behavior in Gscl-/- mice. Gscl is a paralogue of 
goosecoid and a homeobox  transcription factor which recognizes specific DNA 
sequence  (31) and  interacts with a ring finger protein 4 (32). In addition, Dgcr14 
is a nuclear protein with coiled-coil domain (33). These suggest that loss of Gscl 
and Dgcr14 may alter gene or protein expression profiles in the caudal and 
lateral IP subnuclei, resulting in a functional abnormality. 
Gscl and Dgcr14 are among the genes deleted in most individuals with 
DiGeorge syndrome or 22q11 deletion syndrome (20, 33). These patients have 
multiple neuropsychiatric symptoms and susceptible to schizophrenia (18, 34, 
35). Moreover, it has been reported that polymorphisms of DGCR14 are 
significantly associated with schizophrenia (36). Interestingly, Df(16)A+/- mice with 
a microdeletion including Gscl and Dgcr14 gene showed reduced synchrony of 
hippocampal theta with the neuronal activity of the prefrontal cortex (37). 
Together with these finding, the present results suggest that loss of Gscl and 
Dgcr14 affects the regulation of hippocampal theta and REM sleep, which may 
contribute to the psychiatric symptoms frequently seen in 22q11 syndrome 
patients.  
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Materials and Methods 
Animals. Gscl-/- mice and littermate Gscl+/+ mice were derived from Gscl+/- 
parents which were backcrossed for more than 6 generations to the C57BL/6J 
strain (19). Gad67Gfp/+ mice were previously described (22) and crossed to the 
Gscl+/- line. Mice were provided food and water ad lib, maintained on a 12 h light 
dark cycle at all times and were under controlled temperature and humidity 
conditions. All procedures were approved by the Institutional Animal Care and 
Use Committee of the University of Texas Southwestern Medical Center at 
Dallas and were carried out in strict accordance with the National Institute of 
Health Guide for the Care and Use of Laboratory Animals. Genotypes were 
determined by the amplification of genomic DNA by polymerase chain reaction. 
 
EEG/EMG electrode implantation. For chronic electroencephalogram/ 
electromyogram (EEG/EMG) monitoring, 12–14-week-old Gscl-/- and wild-type 
male mice were anesthetized with 40 mg/kg ketamine, 4 mg/kg xylazine and the 
cranium was exposed. Four electrode pins were lowered to the dura under 
stereotaxic control and two flexible for EMG recording were inserted in the neck 
muscle, and then attached to the skull with dental cement. The electrodes for 
EEG signals were positioned over the frontal and occipital cortices (AP, 0.5 mm; 
ML, 1.3 mm; DV, -1.3 mm, and AP, -4.5 mm; ML, 1.3 mm; DV, -1.3 mm). After 
recovery from anesthesia, the mice were individually housed and tethered to a 
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counterbalanced arm (Instech Laboratories, Plymouth Meeting, PA) that allowed 
the mouse to move freely and exerted minimal weight. All mice were then 
allowed 14 days of recovery from surgery and habituation to the recording 
conditions. 
 
EEG/EMG analysis. EEG/EMG signal was recorded continuously for three 
consecutive 24 h periods. EEG/EMG signals were amplified using a Grass Model 
78 (Grass Instruments, West Warwick, RI), filtered (EEG: 0.3-300 Hz, EMG: 30-
300 Hz), digitized at a sampling rate of 250 Hz, and displayed using custom 
polygraph software. The vigilance state in each 20 s epoch was classified as 
NREM sleep, REM sleep, or wakefulness by visual inspection of the EEG and 
EMG signals by two independent observers blinded as to genotype. Total time 
spent in wakefulness, NREM, and REM sleep was derived by summing the total 
number of 20 s epochs in each state. Mean episode durations were determined 
by dividing the total time spent in each state by the number of episodes of that 
state. Mean REM sleep latency was determined by averaging the time elapsed 
from the beginning of a continuous NREM sleep episode to the beginning of the 
subsequent REM sleep episode. Epochs containing movement artifacts were 
included in the state totals but excluded from subsequent spectral analysis. EEG 
signals were subjected to a fast Fourier transform analysis from 1 to 32 Hz with a 
1Hz bin using MatLab (The MathWorks). EEG power density in each frequency 
bin was expressed as a percentage of the mean total EEG power over all 
frequency bins and vigilance states. 
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Arousability Test during REM and NREM sleep. EEG/EMG implanted male 
mice (14-15 weeks old) were tested during the light period (ZT 6-10) in a cage 
equipped with a speaker. An experimenter monitored EEG/EMG signals in a 
room adjacent to the recording room. An 8-kHz, 70-dB, 500-ms pulse of a 
sinusoidal tone was delivered during NREM and REM sleep episodes. The 
number of trials in which mice reacted to the sound, as seen in robust EMG 
signals, were counted over the total number of trials. A similar study adopted a 
Latex glove attached to the end of a long metal rod as the external stimulus 
during videotape recording. Ten seconds after the onset of REM sleep under 
continuous EEG/EMG monitoring, an experimenter gently moved a glove from 3-
m distance from the mouse to 5-cm distance. The latency to awaken was scored 
in real time from the onset of stimulus to apparent wakefulness as indicated by 
the EEG/EMG signals. All experiments were conducted by an experimenter who 
was blinded as to mouse genotype. 
 
REM sleep deprivation. REM sleep deprivation was conducted for 6 h in the 
second half of the light period (ZT 6-12) by gentle handling under EEG/EMG 
monitoring. A REM transition was defined by the reduction of slow wave 
amplitude and appearance of theta wave intermixed with slow waves on the 
EEG, combined with diminishing EMG tonus. After REM sleep deprivation, the 
mice were kept in the same experimental cages under continuous recording of 
the EEG/EMG for a further 24 h. The vigilance state data during the recovery 
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period were compared with baseline data, which were recorded during the period 
prior to the deprivation procedure. 
 
In situ hybridization and histological examinations. Animals were deeply 
anesthetized with ketamine and xylazine, and then perfused with phosphate-
buffered saline, followed by 4% paraformaldehyde. Brains or embryos were 
removed, post-fixed overnight in 4% paraformaldehyde, and then equilibrated in 
20% sucrose for two days. The brains and embryos were then sectioned on a 
freezing microtome at 35 µm and mounted on MAS-coated slide glass 
(Matsunami Glass, Osaka, Japan). The sections were hybridized in situ to a 35S-
labeled Gscl or Dgcr14 sense and antisense probes which were synthesized 
from pGEM-T Easy (Promega) containing the sequence of Gscl or Dgcr14 
mRNA, using a Maxiscript kit (Ambion) in the presence of 35S-CTP (Amersham). 
The slides were developed in Kodak D-19 and counterstained using Nissl stain. 
After fixation and sectioning of Gscl+/+; Gad67Gfp/+ and Gscl-/-; Gad67Gfp/+ brains 
as above, GFP fluorescence was observed under the fluorescence microscope. 
Immunohistochemistry was performed using a free-floating method. The brain 
sections were incubated with antibodies for ChAT (goat polyclonal, AB144, 
Millipore), somatostatin (rabbit polyclonal, AB5494, Millipore), substance P 
(rabbit polyclonal, AB1566, Millipore), Met-enkephalin (rabbit polyclonal, AB5026, 
Millipore), and 5-HTT (rabbit polyclonal, ab44520, abcam) followed by incubation 
with biotinylated anti-rabbit or goat IgG, and then incubated in avidin-biotin-
horseradish peroxidase conjugate (Vector). Positive immunoreactivity was 
 18
visualized using 3,3'-Diaminobenzidine (DAB).  
 
Tracer injection.  Under anesthesia,12–14-week-old Gscl-/- and wild-type male 
mice were placed in a stereotaxic apparatus and, a fine glass pipette was 
positioned in the lateral subnucleus at coordinates (AP,-3.5 mm; ML, 0.3 mm; 
DV, 4.8 mm) according to mouse brain atlas (38). After the injection of tracer, the 
pipette was slowly withdrawn and the incision was closed with sutures. The 
mouse survived for 7 days before being perfused with 4 % paraformaldehyde; 
the brain was then processed for immunostaining. 
As a retrograde tracer, 200 nl of 1% cholera toxin B (List biotechnological 
labs) was injected. Immunostaining was performed using anti-goat cholera toxin 
B (List biotechnological labs) and DAB. As an anterograde tracer, AAV-GFP 
(adeno-associated viral vector containing the gene for green fluorescent protein, 
50-100 nl, Harvard Gene Therapy Initiative Research Vector Core) was used. 
Brain sections were incubated with rabbit anti-GFP antibody (Molecular Probes). 
GFP-positive fibers were visualized with DAB and observed under dark field 
microscopy.  
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Figure legends 
Fig. 1. Normal anatomical structure of the IP of a Gscl-deficient mouse. (A) Gscl 
mRNA expression is restricted to the IP (delineated by broken lines). (B) High 
magnification view of (A) shows that Gscl mRNA is expressed in the IPc and IPl. 
(C, D) During the embryonic stage, Gscl mRNA expression is restricted to the 
developing ventral midbrain/pons transition (arrowhead). (E, F) Both Gscl+/+; 
Gad67Gfp/+ and Gscl-/-; Gad67Gfp/+ mouse have diffuse and moderate Gfp 
expression in the entire IP (delineated by broken lines) with strong expression in 
the rostral subnucleus. (G-K) The IP of Gscl-/- mouse exhibits immunoreactivities 
for Chat (G), somatostatin (Sst, H), substance P (I), Met-enkephalin (J), and 5-
HT transporter (K). (L) The Gscl+/+ mouse has marked expression of Dgcr14 in 
the IPc, IPl, and a part of the intermediate subnucleus (arrow). (M) The Gscl-/- 
mouse did not show an increased expression of Dgcr14 mRNA in the IP 
subnucleus. (N-R) Retrograde tracing from the IP after injection of a retrograde 
tracer, cholera toxin B, in the IPl, labeled-fibers and cells were recognized in the 
MnR (N), DRN (O), LDTg (P) and NI (Q) of Gscl-/- mice and the NI of Gscl+/+ mice 
(R). (S) Injection of an anterograde tracer, AAV-GFP in the IPl revealed GFP-
positive fibers in the PDTg and NI of Gscl-/- mice.mlf, medial longitudinal 
fasciculus. Bars; 300 μm (A,C,N,P,R), 150 μm(E,H). 
  
Fig. 2. Sleep and wakefulness in Gscl-deficient mouse. (A, B, C) Circadian 
variation in wakefulness, NREM sleep, and REM sleep in Gscl+/+ (n=12) and 
Gscl-/- mice (n=6). Data (mean ± SEM) are expressed as minutes per hour spent 
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in each stage, averaged from EEG/EMG recording during three consecutive 24 h 
periods. (D) The value indicates the number (mean ± SEM) of transitions 
between wakefulness, NREM sleep, and REM sleep per 24 h. Gscl-/- mice (left) 
showed reduced transitions from NREM sleep to REM sleep compared with 
Gscl+/+ mice (right). Data (mean + SEM) were subjected to analysis of variance 
(ANOVA) with repeated measurements followed by the Tukey post-hoc test. 
*P<0.05. 
 
Fig. 3. EEG spectral analysis of Gscl-/- mice. (A) EEG spectral profiles of Gscl+/+ 
(gray line, n=12) and Gscl-/- (black line, n=6) mice during wakefulness (right), 
NREM sleep (center), and REM sleep (left). The average EEG spectra were 
normalized to total EEG power from 1 Hz to 32 Hz in 1 Hz bins. (B) Gscl-/- mice 
(red bar) exhibited a reduced power density in the theta frequency band (left)  
during REM sleep, and a greater power density in the delta frequency band 
(right) during NREM sleep, when compared with Gscl+/+ mice (blue bar). Data 
(mean + SEM) were analyzed with ANOVA followed by the Tukey post-hoc test. 
*P<0.05. **P<0.005. 
 
Fig. 4. Arousal response to stimuli during sleep. (A) During REM sleep, Gscl-/- 
mice (n=4) tended to be awakened in response to acoustic stimuli but Gscl+/+ 
mice (n=5) remained asleep (chi-square test, P<0.001). There was no significant 
difference in the arousal response to an approaching object during NREM sleep 
(P=0.2). Numbers in the table denote the number of stimulus trials. (B) The 
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latency of Gscl-/- mice (n=4) in response to an approaching object during REM 
sleep was shorter than that of Gscl+/+ mice (n=5) (Mann-Whitney’s U-test, 
P<0.001). Circles represent individual trials. 
 
Fig. 5. REM sleep rebound after REM sleep deprivation. (A) After 6 h of REM 
sleep deprivation (RSD) from ZT6 to ZT12, the time spent in REM sleep is 
displayed for each 3 h period during the recovery phase from ZT12-ZT24. Both 
Gscl+/+ mice (n= 5) and Gscl-/- mice (n=4) spent more time in REM sleep from 
ZT12 to ZT15 compared with baseline. Gscl-/- mice exhibited a shorter REM 
sleep time than Gscl+/+ mice during ZT12-15, ZT15-18, and ZT21-24. (B) The 
time spent in NREM sleep after 6 h of RSD for each 3 h period from ZT 12-ZT24. 
RSD did not alter NREM time in either Gscl+/+ or Gscl-/- mice. Data (mean + SEM) 
were analyzed with ANOVA followed by the Tukey post-hoc test. *P<0.05 
Table 1.  Sleep/wakefulness parameters 
 Wakefulness  NREM sleep  REM sleep 
  Gscl+/+ Gscl-/- P Gscl+/+ Gscl-/- P Gscl+/+ Gscl-/- P 
24 h      
Time (min) 764±11 730±20 0.071 596±10 649±19 0.011 79.6±2.6 61.0±2.3 <0.0001
Duration (s) 686±46 689±42 0.965 318±11 400±17 0.0002 77.6±1.8 74.5±2.1 0.303
Frequency (episode/h) 2.36±0.14 1.84±0.08 0.003 4.01±0.15 3.17±0.07 <0.0001 2.17±0.08 1.63±0.06 <0.0001
REM sleep latency (min)    8.13±0.25 10.8±0.43 <0.0001
12h light period          
Time (min) 275±8.0 273±5.9 0.88 385±6.4 402±6.0 0.066 60.0±2.6 44.7±2.0 <0.0001
Duration (s) 519±39 579±41 0.35 325±12 430±22 0.0001 81.6±2.3 79.6±2.6 0.602
Frequency (episode/h) 2.36±0.13 1.79±0.10 0.001 4.99±0.16 3.74±0.12 <0.0001 3.16±0.15 2.26±0.09 <0.0001
REM sleep latency (min)    8.17±0.28 10.8±0.46 <0.0001
12h dark period          
Time (min) 490±9.0 457±16 0.054 210±8.8 247±15 0.032 19.5±0.99 16.4±1.1 0.059
Duration (s) 981±91 850±67 0.26 311±14 366±13 0.009 70.8±2.1 65.5±2.0 0.085
Frequency (episode/h) 2.34±0.18 1.93±0.12 0.075 3.02±0.19 2.59±0.15 0.087 1.17±0.06 0.98±0.07 0.065
REM sleep latency (min)    8.11±0.29 11.0±0.61 0.0003
Data are expressed as mean ± SEM for Gscl+/+ (n=12) and Gscl-/- (n=6) mice. All parameters were derived from 
EEG/EMG recording for 3 consecutive 24- h periods. Statistical comparisons are by Student' t test. Significant 
changes (p<0.05) are shown in bold type. 





